Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ursodeoxycholic Acid (300mg)
Therapeutic Category
Gastroenterology, General and OTC medicines, Hepatology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*1*10
Price
₹390/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Uriviga 300 Tablet contains Ursodeoxycholic Acid, a bile acid used primarily in the treatment of various liver and gallbladder disorders. It is effective in dissolving cholesterol gallstones and improving bile flow. Ursodeoxycholic acid helps to reduce the concentration of cholesterol in bile, preventing the formation of new gallstones and promoting the dissolution of existing cholesterol stones. Additionally, it is beneficial in managing conditions like primary biliary cirrhosis, where it helps improve liver function by slowing disease progression and reducing symptoms such as fatigue and itching.
The medication works by enhancing the solubility of cholesterol in bile and preventing the accumulation of harmful substances in the liver. Uriviga 300 Tablet is commonly prescribed to patients with non-alcoholic fatty liver disease (NAFLD), liver damage, and those undergoing gallstone management. It helps in improving liver function, reducing bile acid buildup, and maintaining gallbladder health.
Common side effects include diarrhea, nausea, abdominal discomfort, and headache. Serious side effects, such as liver dysfunction, may require immediate medical attention.
Uriviga 300 Tablet is indicated for the treatment of cholesterol gallstones, primary biliary cirrhosis, non-alcoholic fatty liver disease (NAFLD), and other liver-related conditions.
Consult your doctor before use if you have a history of liver disease or are allergic to Ursodeoxycholic acid. Not recommended for patients with active liver disease.
Store in a cool, dry place at room temperature. Keep away from heat and direct sunlight. Keep out of reach of children.
Composition : Ursodeoxycholic Acid (150mg)
Composition : Ursodeoxycholic Acid (600mg) SR
Composition : Ursodeoxycholic Acid (450mg) SR
Composition : Ursodeoxycholic Acid (125mg/5ml)
Composition : Sodium Bicarbonate (500mg)
Composition : Sodium Bicarbonate (1000mg)
Composition : Obeticholic acid (10mg) Tablet
Composition : Obeticholic acid (5mg) Tablet
Composition : Esomeprazole (40mg)
Composition : Rabeprazole (20mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Uriviga 300 Tablet has growing demand in the urinary health and urology care segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand their portfolio in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent market demand for Uriviga 300 Tablet in urinary tract and urology care segments. Including this product helps strengthen their specialty healthcare and urology medicine portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Uriviga 300 Tablet with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable product supply for distributors and medical agencies.
Wholesalers and medical agencies benefit from attractive business margins, timely product availability, professional marketing support, and access to a trusted pharmaceutical product range when partnering with Cafoli Lifecare for Uriviga 300 Tablet distribution.
Medical distributors, stockists, wholesalers, and pharma professionals interested in Uriviga 300 Tablet can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk supply requirements, pricing details, and distribution support services.